home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 15, 2019
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 528 active entries

Manus Aktteva Biopharma LLP

303, 3rd Floor, Royale Manor, Lawgarden,
Ellisbridge, Ahmedabad, 380006, Gujarat,
India
Toll free: +919879167919, +91 9979866376

Phone: +91-79-65123395
Fax: +91 79 26463395

Description:

 

Manus Aktteva Biopharma LLP, an ISO 9001:2008 certified organization is a well informed, highly efficient, swiftly functioning competitive sourcing entity.

We serve private, institutional and corporate clients worldwide in the field of Pharmaceuticals & Nutraceuticals. We combine our contacts, their expertise and core competency with our operations to deliver superior pharmaceutical sourcing solutions to our customers.

Having our base in India, Manus Aktteva Biopharma LLP has been serving clients in more than 50 countries.

We take pride in fulfilling your requirements of Nutraceuticals, Specialty Chemicals, Pharmaceutical APIs and their advance level intermediates from ISO Certified, GMP, CGMP & USFDA approved units with supportive regulatory documentations like DMF, EDMF, COS, USDMF etc. We wish to state that anyone interested in sourcing any special molecules, APIs, Intermediates, Chiral Compounds etc. and feels it is difficult for early completion of tasks, please call on us and TEST US TO GET THE BEST OF US.

DISCLAIMER :

  • While all due diligence possible will be done and we will cooperate on all matters if any problem arises during course of sourcing , we cannot be held responsible for any non compliance or complications in transaction that may happen, which is beyond our control.
  • Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.

 

PATENTS

ü  Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

ü  Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)

ü  Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Manus Aktteva Biopharma LLP makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.

ü  Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.

ü  Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual.

 

 

The range of Nutraceutical Rawmaterials, Pellets, APIS & Pharma Intermediates offered by us are as follows:

Almotriptan 181183-52-8

Eletriptan hydrobromide 177834-92-3

Frovatriptan succinate hydrate 158930-17-7

Naratriptan hydrochloride 143388-64-1

Rizatriptan benzoate 145202-66-0

Sumatriptan succinate 103628-48-4

Zolmitriptan 139264-17-8

Pramipexole 104632-26-0

N-Acetyl-L-hydroxyproline 33996-33-7

Sertraline hydrochloride 79559-97-0

Brimonidine D-tartrate 70359-46-5

Sumatriptan 103628-46-2

3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol hydrochloride 175591-09-0

Almotriptan 154323-57-6

N-[(4-Aminophenyl)-methylsulfonyl]pyryolidine 334981-10-1

N-[(4-Nitrophenyl)-methylsulfonyl]pyryolidine 340041-91-0

Eletriptan 143322-58-1

4-(Methylamino)cyclohexanone 2,2-dimethyltrimethylene ketal hydrochloride 158747-10-5

Naratriptan 121679-13-8

N-Methyl-1H-indole-5-ethanesulfonamide 98623-50-8

Rizatriptan 144034-80-0

4-(1H-1,2,4-Triazol-1-ylmethyl)aniline 119192-10-8

N-(4-methoxy-2-methylquinolin-6-yl)acetamide 100795-23-1

4,6-Diamino-2-Methyl-Quinoline 5443-31-2

Pramipexole dihydrochloride 104632-25-9

(S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine 106092-09-5

2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole 104617-49-4

 6-Acetamido-2-amino-4,5,6,7-tetrahydrobenzothiazole 104617-51-8

N-(4-Oxocyclohexyl)acetamide 27514-08-5 



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Supplier
- Research
Consulting
- Research
- Strategic
Contract
- Research

Last update of this entry: October 16, 2019

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.